Ohcanbohtosat - Zachary C. Dobbin

  • Čájehuvvo 1 - 12 / 12
Aiddostahte ozu
  1. 1
    The Importance of the PI3K/AKT/MTOR Pathway in the Progression of Ovarian Cancer

    The Importance of the PI3K/AKT/MTOR Pathway in the Progression of Ovarian Cancer Dahkki Zachary C. Dobbin, Charles N. Landen

    Almmustuhtton 2013
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  2. 2
    Tyrosine-phosphorylated Caveolin-1 (Tyr-14) Increases Sensitivity to Paclitaxel by Inhibiting BCL2 and BCLxL Proteins via c-Jun N-terminal Kinase (JNK)

    Tyrosine-phosphorylated Caveolin-1 (Tyr-14) Increases Sensitivity to Paclitaxel by Inhibiting BCL2 and BCLxL Proteins via c-Jun N-terminal Kinase (JNK) Dahkki Ayesha N. Shajahan‐Haq, Zachary C. Dobbin, F. Edward Hickman, Sivanesan Dakshanamurthy, Robert Clarke

    Almmustuhtton 2012
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  3. 3
    Automatic and Quantitative Measurement of Protein-Protein Colocalization in Live Cells

    Automatic and Quantitative Measurement of Protein-Protein Colocalization in Live Cells Dahkki Sylvain V. Costes, Dirk Daelemans, Edward H. Cho, Zachary C. Dobbin, George N. Pavlakis, Stephen Lockett

    Almmustuhtton 2004
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  4. 4
    Smoothened Antagonists Reverse Taxane Resistance in Ovarian Cancer

    Smoothened Antagonists Reverse Taxane Resistance in Ovarian Cancer Dahkki Adam D. Steg, Ashwini A. Katre, Kerri S. Bevis, Angela Ziebarth, Zachary C. Dobbin, Monjri M. Shah, Ronald D. Alvarez, Charles N. Landen

    Almmustuhtton 2012
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  5. 5
    Stem Cell Pathways Contribute to Clinical Chemoresistance in Ovarian Cancer

    Stem Cell Pathways Contribute to Clinical Chemoresistance in Ovarian Cancer Dahkki Adam D. Steg, Kerri S. Bevis, Ashwini A. Katre, Angela Ziebarth, Zachary C. Dobbin, Ronald D. Alvarez, Kui Zhang, Michael Conner, Charles N. Landen

    Almmustuhtton 2011
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  6. 6
    An ex vivo assay of XRT-induced Rad51 foci formation predicts response to PARP-inhibition in ovarian cancer

    An ex vivo assay of XRT-induced Rad51 foci formation predicts response to PARP-inhibition in ovarian cancer Dahkki Monjri M. Shah, Zachary C. Dobbin, Somaira Nowsheen, Monica E. Wielgos, Ashwini A. Katre, Ronald D. Alvarez, Panagiotis A. Konstantinopoulos, Eddy S. Yang, Charles N. Landen

    Almmustuhtton 2014
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  7. 7
    SUZ12 Promotes Human Epithelial Ovarian Cancer by Suppressing Apoptosis via Silencing HRK

    SUZ12 Promotes Human Epithelial Ovarian Cancer by Suppressing Apoptosis via Silencing HRK Dahkki Hua Li, Qi Cai, Hong Wu, Vinod Vathipadiekal, Zachary C. Dobbin, Tianyu Li, Hua Xiang, Charles N. Landen, Michael J. Birrer, Margarita Sánchez‐Beato, Rugang Zhang

    Almmustuhtton 2012
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  8. 8
    Using heterogeneity of the patient-derived xenograft model to identify the chemoresistant population in ovarian cancer

    Using heterogeneity of the patient-derived xenograft model to identify the chemoresistant population in ovarian cancer Dahkki Zachary C. Dobbin, Ashwini A. Katre, Adam D. Steg, Britt Erickson, Monjri M. Shah, Ronald D. Alvarez, Michael Conner, David A. Schneider, Dongquan Chen, Charles N. Landen

    Almmustuhtton 2014
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  9. 9
    Targeting RNA-Polymerase I in Both Chemosensitive and Chemoresistant Populations in Epithelial Ovarian Cancer

    Targeting RNA-Polymerase I in Both Chemosensitive and Chemoresistant Populations in Epithelial Ovarian Cancer Dahkki Robert Cornelison, Zachary C. Dobbin, Ashwini A. Katre, Dae Hoon Jeong, Yinfeng Zhang, Dongquan Chen, Yuliya Petrova, Danielle C. Llaneza, Adam D. Steg, Laura Parsons, David A. Schneider, Charles N. Landen

    Almmustuhtton 2017
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  10. 10
    Endoglin (CD105) Contributes to Platinum Resistance and Is A Target for Tumor-Specific Therapy in Epithelial Ovarian Cancer

    Endoglin (CD105) Contributes to Platinum Resistance and Is A Target for Tumor-Specific Therapy in Epithelial Ovarian Cancer Dahkki Angela Ziebarth, Somaira Nowsheen, Adam D. Steg, Monjri M. Shah, Ashwini A. Katre, Zachary C. Dobbin, Hee‐Dong Han, Gabriel López-Berestein, Anil K. Sood, Michael Conner, Eddy S. Yang, Charles N. Landen

    Almmustuhtton 2012
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  11. 11
    Detection of Somatic TP53 Mutations in Tampons of Patients With High-Grade Serous Ovarian Cancer

    Detection of Somatic TP53 Mutations in Tampons of Patients With High-Grade Serous Ovarian Cancer Dahkki Britt Erickson, Isaac Kinde, Zachary C. Dobbin, Yuxuan Wang, J. Martin, Ronald D. Alvarez, Michael Conner, Warner K. Huh, Richard B.S. Roden, Kenneth W. Kinzler, Nickolas Papadopoulos, Bert Vogelstein, Luis A. Díaz, Charles N. Landen

    Almmustuhtton 2014
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  12. 12
    Molecular Response to Neoadjuvant Chemotherapy in High-Grade Serous Ovarian Carcinoma

    Molecular Response to Neoadjuvant Chemotherapy in High-Grade Serous Ovarian Carcinoma Dahkki Rebecca C. Arend, Angelina I. Londoño, Allison M. Montgomery, Haller J. Smith, Zachary C. Dobbin, Ashwini A. Katre, Alba Martínez, Eddy S. Yang, Ronald D. Alvarez, Warner K. Huh, Kerri S. Bevis, J. Michael Straughn, Jacob M. Estes, Lea Novak, David K. Crossman, Sara J. Cooper, Charles N. Landen, Charles A. Leath

    Almmustuhtton 2018
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:

Ohcanreaiddut: